Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Iron and associated redox complexes represent a broad category of metalloproteins and chemical clusters, such as iron-sulfur (Fe-S) clusters and heme groups, that utilize the redox-active properties of iron to facilitate essential biological processes. These complexes are central to cellular respiration within the mitochondrial electron transport chain, DNA synthesis and repair, and the transport of oxygen (NIH, 2023). Because iron can cycle between oxidation states (Fe2+ and Fe3+), it is a critical cofactor for enzymes like ribonucleotide reductase and cytochromes, but this same reactivity can lead to the production of harmful reactive oxygen species through Fenton chemistry if not strictly regulated (PubMed, PMID: 31505829). In clinical practice, these complexes are targeted through iron chelation therapy to treat iron overload disorders or by iron supplementation for deficiency anemias. Furthermore, emerging research in oncology focuses on exploiting the 'iron addiction' of cancer cells and the induction of ferroptosis, a form of regulated cell death driven by iron-dependent lipid peroxidation (Nature Reviews Cancer, 2020). While 'Iron and associated redox complexes' is a functional grouping rather than a single molecular target, it encompasses several high-value therapeutic nodes in metabolism and oxidative stress management.
Iron chelators bind free or labile iron to prevent the formation of reactive oxygen species (ROS) via Fenton chemistry; iron supplements provide essential iron for heme and Fe-S cluster synthesis; certain inhibitors target specific iron-dependent enzymes like ribonucleotide reductase or mitochondrial respiratory complexes.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Iron and associated redox complexes (Fe-redox complexes).